Cellular and Molecular Immunoregulation Research Group
Two patients suffer from the same type of cancer. One of them recovers, whereas the other dies. The one key factor that decides which patient loses and which one wins is the immune system. The condition and functioning of the immune system can be affected to a certain extent; using immunoregulation, one can achieve better prognoses in cancer patients. The research team is examining in detail cellular signalization, which controls natural immune research during sepsis and aging.
The team is developing experimental models dealing with the role of hematopoietic precursors and mesenchymal stem cells in the relationship between immune reactions and tissue regeneration. It is also focusing on the main sensors of infections and tissue damage and the circumstances that govern acute and chronic inflammatory diseases accompanying tissue regeneration and the aging process. A better understanding of these processes may help to create a new strategy for treating inflammatory diseases.